GenMark Diagnostics to Present at the William Blair 2014 Growth Stock Conference
June 06 2014 - 02:59PM
Business Wire
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will
present at the William Blair 2014 Growth Stock Conference to be
held at the Four Seasons Hotel in Chicago, IL on Wednesday, June
11, 2014. The presentation will be delivered by Hany Massarany,
President and Chief Executive Officer, and is scheduled to begin at
3:20 p.m. Central Time (1:20 p.m. Pacific Time). The presentation
will be made available at http://ir.genmarkdx.com/.
ABOUT GENMARK
GenMark Diagnostics is a leading provider of automated,
multiplex molecular diagnostic testing systems that detect and
measure DNA and RNA targets to diagnose disease and optimize
patient treatment. Utilizing GenMark's proprietary eSensor®
detection technology, GenMark's eSensor® XT-8 system is designed to
support a broad range of molecular diagnostic tests with a compact,
easy-to-use workstation and self-contained, disposable test
cartridges. GenMark currently markets four tests that are FDA
cleared for IVD use: Cystic Fibrosis Genotyping Test, Respiratory
Virus Panel, Thrombophilia Risk Test, and Warfarin Sensitivity
Test. A number of other tests, including HCV Genotyping, 2C19
Genotyping, and 3A4/3A5 Genotyping are available for research use
only. For more information, visit www.genmarkdx.com.
GenMark Diagnostics, Inc.Hany MassaranyPresident, Chief
Executive Officer760-448-4358
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Feb 2024 to Mar 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Mar 2023 to Mar 2024